CD27 Expressing B-cell Malignancies for Example Hodgkin's Lymphoma

Clinical trial pipeline · Data from ClinicalTrials.gov

See which CD27 Expressing B-cell Malignancies for Example Hodgkin's Lymphoma trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

CompletedPhase 1

NCT01460134

A Study of CDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic Cancers

This is a study of CDX-1127, a therapy that targets the immune system and may act to promote anti-cancer effects. The study enrolls patients with hematologic ca…

United States90 participantsStarted 2011-10

Treatment: CDX-1127, CDX-1127